National Facilitators and Barriers to the Implementation of Incentives for Antibiotic Access and Innovation
Prominent reports have assessed the challenges to antibiotic innovation and recommended implementing "pull" incentives, i.e., mechanisms that give increased and predictable revenues for important, marketed antibiotics. We set out to understand countries' perceptions of these recommend...
Saved in:
Main Authors: | Christine Årdal (Author), Yohann Lacotte (Author), Suzanne Edwards (Author), Marie-Cécile Ploy (Author), on behalf of the European Union Joint Action on Antimicrobial Resistance and Healthcare-Associated Infections (EU-JAMRAI) (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Linking sustainable use policies to novel economic incentives to stimulate antibiotic research and development
by: Ursula Theuretzbacher, et al.
Published: (2017) -
Characterization of Carbapenemase- and ESBL-Producing Gram-Negative Bacilli Isolated from Patients with Urinary Tract and Bloodstream Infections
by: Isabella A. Tickler, et al.
Published: (2023) -
The Treaty of the European Union, Maastricht Treaty, 7th February, 1992
by: European Union -
Educating, training, and exercising for infectious disease control with emphasis on cross-border settings: an integrative review
by: Doret de Rooij, et al.
Published: (2020) -
Assessing training needs in infectious disease management at major ports, airports and ground-crossings in Europe
by: Doret de Rooij, et al.
Published: (2021)